| 000 | 01862 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516051051.0 | ||
| 264 | 0 | _c20110921 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1549-4713 | ||
| 024 | 7 |
_a10.1016/j.ophtha.2011.02.048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPearson, P Andrew | |
| 245 | 0 | 0 |
_aFluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. _h[electronic resource] |
| 260 |
_bOphthalmology _cAug 2011 |
||
| 300 |
_a1580-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCataract _xchemically induced |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdiagnosis |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluocinolone Acetonide _xadministration & dosage |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 |
_aMacular Edema _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRetina _xdrug effects |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 650 | 0 | 4 |
_aVitreous Body _xdrug effects |
| 700 | 1 | _aComstock, Timothy L | |
| 700 | 1 | _aIp, Michael | |
| 700 | 1 | _aCallanan, David | |
| 700 | 1 | _aMorse, Lawrence S | |
| 700 | 1 | _aAshton, Paul | |
| 700 | 1 | _aLevy, Brian | |
| 700 | 1 | _aMann, Eric S | |
| 700 | 1 | _aEliott, Dean | |
| 773 | 0 |
_tOphthalmology _gvol. 118 _gno. 8 _gp. 1580-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ophtha.2011.02.048 _zAvailable from publisher's website |
| 999 |
_c21058450 _d21058450 |
||